BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3486004)

  • 1. Analysis of ras oncogene products by two-dimensional gel electrophoresis: evidence for protein families with distinctive molecular forms.
    Fuhrer JP; DeBiasi F; Cooper HL; Schlom J
    Biochim Biophys Acta; 1986 May; 866(4):204-15. PubMed ID: 3486004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of quantitative liquid competition radioimmunoassays for the ras oncogene and proto-oncogene p21 products.
    Caruso A; Schlom J; Vilasi V; Weeks MO; Hand PH
    Int J Cancer; 1986 Oct; 38(4):587-95. PubMed ID: 3489681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of p21 proteins from various cell types by two-dimensional gel electrophoresis.
    Feuerstein N; Ali IU
    J Cell Biochem; 1985; 29(3):253-63. PubMed ID: 3001111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute values of ras p21 defined by direct binding liquid competition radioimmunoassays.
    Horan Hand P; Vilasi V; Caruso A; Schlom J
    Biochim Biophys Acta; 1987 Feb; 908(2):131-42. PubMed ID: 3814600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-dimensional polyacrylamide gel electrophoresis analysis of phosphorylated, membrane-localized ras p21 proteins.
    Polonis VR; Anderson GR; Doyle D
    Arch Biochem Biophys; 1987 May; 254(2):541-6. PubMed ID: 3555345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
    Pullano TG; Sinn E; Carney WP
    Oncogene; 1989 Aug; 4(8):1003-8. PubMed ID: 2474786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of activated Mr 21,000 protein, the product of ras oncogenes, using antibodies with specificity for amino acid 12.
    Wong G; Arnheim N; Clark R; McCabe P; Innis M; Aldwin L; Nitecki D; McCormick F
    Cancer Res; 1986 Dec; 46(12 Pt 1):6029-33. PubMed ID: 3490906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of ras oncogenes by analysis of p21 proteins in human tumor cell lines.
    Fujita J; Yoshida O; Ebi Y; Nakayama H; Onoue H; Rhim JS; Kitamura Y
    Urol Res; 1988; 16(6):415-8. PubMed ID: 3068879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence and possible role of c-ras and nuclear (c-fos and c-jun) proto-oncogene products in preimplantation embryonic development in mice.
    Ahmad K; Naz RK
    Mol Reprod Dev; 1993 Nov; 36(3):297-306. PubMed ID: 8286110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein.
    Feramisco JR; Clark R; Wong G; Arnheim N; Milley R; McCormick F
    Nature; 1985 Apr 18-24; 314(6012):639-42. PubMed ID: 2581140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of anti-RAS p21 monoclonal antibodies.
    Hamer PJ; Trimpe KL; Pullano T; Ng S; LaVecchio JA; Petit DA; DeLellis R; Wolfe H; Carney WP
    Hybridoma; 1990 Dec; 9(6):573-87. PubMed ID: 2076896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
    Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
    Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of transforming ras proteins containing leucine at position 61 by a new mouse monoclonal antibody, ras(53-69)Leu61.
    Bizub D; Fischberg-Bender E; Heimer EP; Felix A; Skalka AM
    Cancer Res; 1989 Nov; 49(22):6425-31. PubMed ID: 2680065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.
    Bradley MO; Kraynak AR; Storer RD; Gibbs JB
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5277-81. PubMed ID: 3523488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of enhancement of the ras oncogene protein product (p21) in a spectrum of human tumors.
    De Biasi F; Del Sal G; Hand PH
    Int J Cancer; 1989 Mar; 43(3):431-5. PubMed ID: 2784420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of ras oncogene p21 protein in relation to regional spread of human breast carcinomas.
    Czerniak B; Chen R; Tuziak T; Markiewski M; Kram A; Gorczyca W; Deitch D; Herz F; Koss LG
    Cancer; 1989 May; 63(10):2008-13. PubMed ID: 2467732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of monoclonal antibodies to Ha-ras and N-ras p21.
    Ng S; Conlon J; Lavecchio J; Hamer PJ; Pullano T; Carney WP
    Hybridoma; 1991 Aug; 10(4):467-80. PubMed ID: 1937497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting morphological changes in PC12 flat cells expressing two different forms of exogenous oncogenic ras.
    Rozenberg YY; Howard BD
    Exp Cell Res; 1994 Mar; 211(1):59-67. PubMed ID: 8125159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative two-dimensional gel electrophoresis analysis of human fibroblasts transformed by ras oncogenes.
    Miller MJ; Maher VM; McCormick JJ
    Electrophoresis; 1992 Nov; 13(11):862-70. PubMed ID: 1483428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.